DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $10 million in its first quarter.

The Dublin-based company said it had a loss of 2 cents per share. Losses, adjusted for stock option expense, were 1 cent per share.

The biopharmaceutical company posted revenue of $56.5 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $51.3 million.

The company's shares closed at 92 cents. A year ago, they were trading at $1.38.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News